MRNS | Marinus Pharmaceuticals Inc 12.46 -0.11 (-0.89%)
Category: Consumer goods
Quick infos Trade prices Volume: Market Cap: Prev closed: Open: High: Low: 52 week low: 52 week high: Dividends:
Earnings History Date EPS / Forecast Revenue / Forecast November 9, 2020 -0.51 / -0.60.17M / 281.25KOctober 29, 2020 - / -0.17- / -August 11, 2020 - / -0.19- / -May 4, 2020 -0.32 / -0.16- / -March 16, 2020 -0.25 / -0.21- / 5Mview more
Historical Data Date Price Open High Low Vol Change ER Dec 11, 2020 12.950 13.470 13.890
12.900
606.05K -4.85% Dec 10, 2020 13.610 13.330 13.620
12.660
967.31K 0.07% Dec 9, 2020 13.600 13.950 14.050
13.260
1.42M -1.16% Dec 8, 2020 13.760 14.310 14.340
13.680
3.89M -11.85% Dec 7, 2020 15.610 14.900 15.690
14.570
599.46K 7.10% Dec 4, 2020 14.575 14.730 14.958
14.350
519.10K 0.24% Dec 3, 2020 14.540 14.850 15.100
14.450
656.54K -1.96% Dec 2, 2020 14.830 15.700 15.700
14.390
958.00K -6.67% Dec 1, 2020 15.890 16.150 17.140
15.790
1.29M 0% Nov 30, 2020 15.890 14.690 16.215
14.331
1.21M 8.54% view more
News
Marinus Pharmaceuticals Announces Proposed Public Offering of Common Stock finance.yahoo.com Oct 16, 2020 4:01 pm
A Look At Benzinga Pro's Most-Searched Tickers For September 27, 2019 finance.yahoo.com Oct 16, 2020 3:08 pm
Marinus Shares Rip Higher On Positive Ganaxolone Midstage Data In Epileptic Seizures finance.yahoo.com Oct 16, 2020 11:16 am
Nasdaq Rises Despite Nikola Hit; Marinus Soars fool.com Oct 16, 2020 10:38 am
Corrected Press Release: Marinus Pharmaceuticals Announces Pricing of $65 Million Public Offering of Common Stock and Concurrent Private Placement finance.yahoo.com Oct 16, 2020 10:31 am
Broadcom (AVGO) to Report Q1 Earnings: What's in the Offing? finance.yahoo.com Oct 16, 2020 9:55 am
Looking Into Marinus Pharmaceuticals's Return On Capital Employed finance.yahoo.com Oct 16, 2020 9:55 am
Marinus Pharmaceuticals Provides Business Update and Reports First Quarter 2019 Financial Results finance.yahoo.com Oct 16, 2020 7:30 am
Hedge Funds Are Crazy About Marinus Pharmaceuticals Inc (MRNS) finance.yahoo.com Oct 14, 2020 10:54 pm Marinus initiated with Buy at Truist on ganaxolone's expected success seekingalpha.com Oct 1, 2020 3:20 am Marinus closing in on launch of pivotal study of ganaxolone in life-threatening type of epilepsy seekingalpha.com Sep 25, 2020 4:52 am Marinus reverse split shares 1:4 seekingalpha.com Sep 22, 2020 9:28 pm
Marinus Announces One-for-Four Reverse Stock Split finance.yahoo.com Sep 22, 2020 9:14 am
Is Marinus Stock Still Worth Buying After Its 50% Rally? This Analyst Says
Yes finance.yahoo.com Sep 16, 2020 7:18 am Marinus Pharma, Accel Entertainment: 5 Stock Gainers for Tuesday thestreet.com Sep 16, 2020 5:18 am
MRNS Catches Eye, SAVA Soars On Alzheimer's Study, ETNB Abuzz Over NASH
Trial, GILD Snaps Up IMMU nasdaq.com Sep 15, 2020 3:18 pm
Ganaxolone Achieves Primary Endpoint in Phase 3 Trial for CDKL5 Deficiency Disorder (CDD), a Rare Form of Genetic Epilepsy finance.yahoo.com Sep 14, 2020 4:01 pm
Marinus Pharmaceuticals to Participate at Three Upcoming Investor Healthcare Conferences finance.yahoo.com Sep 8, 2020 4:01 pm
Here's Why Marinus Pharmaceuticals Is Sinking Today finance.yahoo.com Aug 13, 2020 4:12 pm
Marinus Pharmaceuticals Announces Closing of $70 Million Public Offering of Common Stock and Concurrent Private Placement Including Full Exercise of Underwriters Option to Purchase Additional Shares finance.yahoo.com Aug 13, 2020 4:01 pm Talk about Marinus Pharmaceuticals Inc below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you are looking for News & events, Press Release, they are available on their Investors Relations site.
If you want to help pay for server cost or for improving this tool. You can send it via Paypal .
Buy on Amazon Graham's philosophy of "value investing" has made The Intelligent Investor the stock market bible ever since its original publication in 1949.
The best book on investing ever written.
